Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions
Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them…
Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them…
The path from novel science to a functional business model is rarely a straight one. Besides regulatory hurdles, there remain…
The gene therapy market is predicted to experience rapid growth over the coming years. But with that growth will come many complexities…
A vast range of specialty commercial drug products require temperature-controlled distribution and storage to ensure quality, safety, and efficacy. Some of…
Lung cancer is the leading cause of cancer deaths globally. Non-small cell lung cancer, which originates from larger cells such…
Australia’s life sciences sector has seen rapid growth in the past decade. According to a 2022 report by AusBiotech, the…
Biomanufacturing has had an interesting couple of years. Unprecedented spikes in demand from the global COVID-19 pandemic have been followed…
According to the latest data from CISCRP, the physical location/proximity of a research study center is one of the most…
Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…
The expansion at Macungie will offer increased capacity for secondary packaging activities including Vial Labeling, Pre-Filled Syringe (PFS) assembly and labeling, Autoinjector/Pen assembly…